Filing Details

Accession Number:
0001209191-18-038426
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-18 19:46:23
Reporting Period:
2018-06-14
Accepted Time:
2018-06-18 19:46:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Nutrition Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311283 Robert Levy 800 W. Olympic Boulevard, #406
Los Angeles CA 90015
Evp, The Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-14 10,008 $29.99 522,996 No 4 M Direct
Common Stock Disposition 2018-06-14 5,559 $54.00 517,437 No 4 D Direct
Common Stock Disposition 2018-06-14 2,343 $54.00 515,094 No 4 F Direct
Common Stock Acquisiton 2018-06-14 21,206 $15.22 536,300 No 4 M Direct
Common Stock Disposition 2018-06-14 5,977 $54.00 530,323 No 4 D Direct
Common Stock Disposition 2018-06-14 8,019 $54.00 522,304 No 4 F Direct
Common Stock Disposition 2018-06-18 9,316 $54.00 512,988 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-06-14 10,008 $0.00 10,008 $29.99
Common Stock Stock Appreciation Rights Disposition 2018-06-14 21,206 $0.00 21,206 $15.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-04-30 2024-04-30 No 4 M Direct
0 2018-03-02 2025-03-02 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2018.
  2. The reporting person received 2,106 shares of common stock upon the net exercise of 10,008 stock appreciation rights ("SARs"). The reporting person forfeited 5,559 shares of common stock underlying such SARs in payment of the exercise price and 2,343 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00.
  3. The reporting person received 7,210 shares of common stock upon the net exercise of 21,206 SARs. The reporting person forfeited 5,977 shares of common stock underlying such SARs in payment of the exercise price and 8,019 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on June 14, 2018 of $54.00.
  4. These SARs were previously reported as covering 5,004 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
  5. These SARS were previously reported as covering 10,603 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.